News
-
-
-
PRESS RELEASE
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
Lexaria Bioscience Corp. announces DehydraTECH-semaglutide shows significant reduction in gastrointestinal side effects compared to Rybelsus®, with recent financings enabling new 2026 development opportunities -
-
-
-
-
PRESS RELEASE
NuRAN Announces Closing of the Restructuring Transaction and Initial Tranche of Additional Debt Settlements
NuRAN Wireless Inc. announces successful Closure of Restructuring Transaction and appointment of new director, Joseph Labkowski. Company focuses on rural telecommunications infrastructure -
-